atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
14 Settembre 2023 - 2:02PM
atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage
biopharmaceutical company aiming to transform the treatment of
mental health disorders, will participate in the 2023 Cantor
Fitzgerald Global Healthcare Conference.
Details of the company’s participation is as follows:
2023 Cantor Fitzgerald Global Healthcare
Conference
Format: Fireside Chat
Date and Time: Thursday, September 28th at 1:50 P.M. ET
Location: New York, NY
A webcast of the company’s fireside chat will be available on
atai’s website under Events on the Investors section of the atai
website: https://ir.atai.life/news-events/events/. A replay will be
available following the live event.
About atai Life Sciencesatai is a
clinical-stage biopharmaceutical company aiming to transform the
treatment of mental health disorders and was founded as a response
to the significant unmet need and lack of innovation in the mental
health treatment landscape. atai is dedicated to efficiently
developing innovative therapeutics to treat depression, anxiety,
addiction, and other mental health disorders.
By pooling resources and best practices, atai aims to
responsibly accelerate the development of new medicines to achieve
clinically meaningful and sustained behavioral change in mental
health patients.
atai's vision is to heal mental health disorders so that
everyone, everywhere can live a more fulfilled life. For more
information, please visit www.atai.life.
Contact Information
Investor Contact:IR@atai.life
Media Contact:PR@atai.life
Grafico Azioni ATAI Life Sciences NV (NASDAQ:ATAI)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni ATAI Life Sciences NV (NASDAQ:ATAI)
Storico
Da Mag 2023 a Mag 2024